Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.2
Consolidated Balance Sheets - USD ($)
May 31, 2019
Aug. 31, 2018
Current Assets    
Cash and cash equivalents $ 286,439 $ 337,424
Prepaid expenses 26,427 35,384
Deferred offering costs 291,670  
Deposits 540,917 1,500
Other receivable 6,942 22,127
Total Current Assets 1,152,395 396,435
Equipment, net of accumulated depreciation of $646 and $282, respectively 857 563
TOTAL ASSETS 1,153,252 396,998
Current Liabilities    
Accounts payable and accrued liabilities 912,413 529,272
Due to related party 6,282 2,700
Derivative liability 100,178  
Total Current Liabilities 1,018,873 531,972
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred Stock, par value $0.001, 6,250,000 shares authorized, 0 and 0 shares issued and outstanding as of May 31, 2019 and August 31, 2018, respectively
Common Stock, par value $0.001, 18,750,000 shares authorized, 2,101,140 and 1,750,268 shares issued and outstanding as of May 31, 2019 and August 31, 2018, respectively 2,101 1,750
Additional paid-in capital 4,107,660 2,514,136
Accumulated deficit (3,965,155) (2,638,580)
Accumulated other comprehensive loss (10,227) (12,280)
Total Stockholders' Equity (Deficit) 134,379 (134,974)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 1,153,252 $ 396,998